Defining Inflammatory Biomarkers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Why Is This Research Study Being Conducted? * The study wants to find out why people with a type of blood cancer called myelodysplastic syndromes (MDS) are more likely to have heart problems like heart disease and stroke. * Researchers also want to see if certain proteins related to inflammation in the body can help predict these heart issues in MDS patients. * By understanding this better, researchers hope to find new ways to detect and manage heart disease risks in people with MDS

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥18 years

• Histologically confirmed diagnosis of MDS by bone marrow biopsy morphology, using the 2022 World Health Organization (WHO) classification for myeloid neoplasms

• Eastern Cooperative Oncology Group (ECOG) performance status ≤3

• Expected survival of at least 6 months

• Ability to provide consent

Locations
United States
Vermont
University of Vermont
RECRUITING
Burlington
Contact Information
Primary
Diego Adrianzen Herrera, MD
dadrianz@med.uvm.edu
(802) 656-2021
Backup
Neil A Zakai, MD
neil.zakai@med.uvm.edu
(802) 656-2021
Time Frame
Start Date: 2024-11-05
Estimated Completion Date: 2027-11
Participants
Target number of participants: 30
Treatments
Adults with Myelodysplastic syndromes
All participants will be in one group. Participants will by adults with Myelodysplastic syndromes. Blood will be taken at regular appointments that are part of standard care.
Related Therapeutic Areas
Sponsors
Leads: University of Vermont

This content was sourced from clinicaltrials.gov